-
Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key Companies - F. Hoffmann-La Roche, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Sanofi, Grifols, Regeneron
25 Apr 2024 17:00 GMT
… as tiotropium, find … drugs for treatment … Antidepressants (TCA), Monoamine Oxidase Inhibitors (MAOI), and Others
Pulmonary Drugs … MediciNova, Edesa Biotech, Light Chain Biosciences, Boehringer Ingelheim, Genentech, Windtree Therapeutics, Biomarck Pharmaceuticals …
-
Episode 2: COPD: The Right Inhaled Medication at the Right Price
26 Mar 2024 15:03 GMT
… about medications. He was discharged from the hospital with a tiotropium soft … lot of experience teaching other doctors about how to use inhalers … eliminating the cost sharing for drugs in the catastrophic phase of …
-
2023 First Generic Drug Approvals
08 Mar 2024 22:36 GMT
… Package
B. Braun Medical, Inc.
Calcium Gluconate … Inc
Spiriva HandiHaler (Tiotropium Bromide) Inhalation Powder
… once-daily, maintenance treatment of bronchospasm associated … 0.064%
Glenmark Pharmaceuticals LimitedGlenmark Pharmaceuticals Limited
Enstilar ( …
-
Case Study Suggests Tezepelumab Efficacy for Non-Type 2 Asthma Treatment
05 Mar 2024 01:24 GMT
… of respiratory medicine, at Minami-Nara General Medical Center, … which developed during tezepelumab treatment, after failed treatment with BT, benralizumab … aspirin.
Despite being on tiotropium bromide hydrate, high- … did acknowledge that the drug’s use among …
-
Medication Adherence in Children with Asthma
05 Mar 2024 06:48 GMT
… trial of treatment with inhaled corticosteroids. For a trial of treatment … LAMA) such as tiotropium bromide can be added … to Deliver Medication
Corticosteroid containing medications are delivered … PJ. Inhaled Corticosteroids. Pharmaceuticals. 2010;3(3):514 …
-
Human medicines European public assessment report (EPAR): Rolufta Ellipta (previously Rolufta), umeclidinium, Date of authorisation: 20/03/2017, Revision: 12, Status: Authorised
13 Feb 2024 18:36 GMT
… treatment), while one study compared Rolufta Ellipta with tiotropium (another medicine … after 12 weeks of treatment and by 115 ml … after 24 weeks of treatment. A double dose of … tiotropium, FEV1 improvements over 24 weeks were similar for both medicines …
-
Human medicines European public assessment report (EPAR): Incruse Ellipta (previously Incruse), umeclidinium bromide, Date of authorisation: 28/04/2014, Revision: 19, Status: Authorised
13 Feb 2024 18:36 GMT
… treatment), while one study compared Incruse Ellipta with tiotropium (another medicine … after 12 weeks of treatment and by 115 ml … after 24 weeks of treatment. A double dose of … tiotropium, FEV1 improvements over 24 weeks were similar for both medicines …
-
Inpatient Admissions and Re-Admissions in Medicare Beneficiaries Initiating Umeclidinium/Vilanterol or Tiotropium Therapy
13 Feb 2024 10:41 GMT
… tiotropium bromide; UMEC, umeclidinium; VI, vilanterol.
Follow-Up
Regardless of treatment … Medicaid, which may explain the disparities between the studies.
Several clinical trials … pharmaceutical, device, government, and non-government organizations. STATinMED …
-
Theravance’s Yupelri falls short in Phase IV COPD trial
05 Feb 2024 15:40 GMT
US-based biotech Theravance Biopharma’s chronic obstructive pulmonary disease (COPD) drug Yupelri … Spiriva (tiotropium).
Findings from a separate Phase III clinical trial in China … the FDA – it was secured in November 2018 following two clinical trials …
-
Boehringer Ingelheim Korea initiates voluntary recall for COPD and asthma treatment
31 Jan 2024 02:02 GMT
… : tiotropium bromide hydrate), its chronic obstructive pulmonary disease (COPD) and asthma medication … as an add-on maintenance treatment for severe asthma in children … and an inhaler, with the drug indicator allowing users to ascertain …